Science Explorer Back to mapMap
Discussion
Researcher · Synta Pharmaceuticals (United States) · United States

Gerard M. McGeehan

Gerard M. McGeehan publishes mostly in Molecular Biology, Hematology and Oncology, on topics such as Acute Myeloid Leukemia Research, Protein Degradation and Inhibitors and Hormonal Regulation and Hypertension.

OpenAlex
World rank
#555,561
of 7,710,434 ranked researchers
Rank in United States
#191,881
of 1,627,098
Works
106
Citations
6.2k
Citations per work
59.0
h-index
31
i10-index 56Top 14% in Molecular Biology
Gerard M. McGeehan

What does Gerard M. McGeehan research?

Gerard M. McGeehan's work is mostly in Biochemistry, Genetics and Molecular Biology (33%), Medicine (32%).

Everything else: 37 works · 34.9% of their workLife Sciences: 35 works · 33.2% of their workBiochemistry, Genetics and Molecular Biology: 35 works · 33.2% of their workMolecular Biology: 30 works · 28.4% of their workCancer Research: 5 works · 4.8% of their workHealth Sciences: 34 works · 31.9% of their workMedicine: 34 works · 31.9% of their workHematology: 17 works · 16.3% of their workOncology: 7 works · 6.2% of their workEndocrinology, Diabetes and Metabolism: 6 works · 5.9% of their workCardiology and Cardiovascular Medicine: 4 works · 3.5% of their workTHEIR WORKGerard M.McGeehan106works
Life Sciences33%Health Sciences32%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
  1. Everything else3734.9%
    1. Biochemistry, Genetics and Molecular Biology3533.2%
    1. Medicine3431.9%
  1. 1Molecular Biology28% of their works
  2. 2Hematology16% of their works
  3. 3Oncology6% of their works
  4. 4Endocrinology, Diabetes and Metabolism6% of their works
  5. 5Cancer Research5% of their works
  6. 6Cardiology and Cardiovascular Medicine4% of their works

Research topics

Which keywords describe Gerard M. McGeehan's research?

The keywords of their largest research topics: Acute Myeloid Leukemia, AML, BET Bromodomains, PROTACs, Hypertension, Angiogenesis, Cancer Therapy and Aldosterone.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.

All 19 words, with their numbers
  1. AML321 topic
  2. Acute Myeloid Leukemia321 topic
  3. BET Bromodomains281 topic
  4. PROTACs281 topic
  5. Hypertension222 topics
  6. Angiogenesis212 topics
  7. Cancer Therapy192 topics
  8. Aldosterone131 topic
  9. Primary Aldosteronism131 topic
  10. Matrix Metalloproteinases121 topic
  11. Tissue Inhibitors of Metalloproteinases121 topic
  12. HDAC Inhibitors101 topic
  13. Histone Deacetylases101 topic
  14. Angiotensin91 topic
  15. Fibroblast Activation Protein91 topic
  16. Renin91 topic
  17. Tumor Microenvironment91 topic
  18. Diagnosis Criteria71 topic
  19. International Myeloma Working Group71 topic

Where does Gerard M. McGeehan work?

Gerard M. McGeehan's main affiliation in the publication record is Synta Pharmaceuticals (United States), United States.

How many publications and citations does Gerard M. McGeehan have?

OpenAlex counts 106 works and 6,249 citations for Gerard M. McGeehan, an h-index of 31, ranking #555,561 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Gerard M. McGeehan. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.